Using Real-world Data to Replicate Randomized Clinical Trial Results
The FDA intends to issue guidance on using real-world evidence (RWE) to aid in decisions about product effectiveness. Currently, there [...]
World’s Most Expensive Prescription Drug Shows Promise in Trial
Episalvan, an orphan drug for a condition called epidermolysis bullosa, is an EMA-approved drug for partial thickness wounds. Shortly after [...]
Clinical Trial Design from a Program Perspective
Join Cytel’s co-founder, Nitin Patel, as he discusses the value in designing clinical trials from a program-level perspective. This webinar [...]
Challenge and opportunity abound Through Remote Patient Monitoring
Identifying a cohort and then recruiting and monitoring clinical trial patients is an expensive and time-consuming exercise. Remote Patient Monitoring [...]
When it Comes to COVID-19 Research, The US Still Has A lot to Learn
The US is thought to have the most talented scientists along with the best biomedical research infrastructure in the world. [...]
Rho Experts to Explore Decentralized Trials
Rho's Rob Woolson and Derek Lawrence will discuss in an upcoming webinar how the company is helping trial sponsors get [...]
Article Spotlights Virtual Component of ADAPTABLE Study
A recent Clinical Leader article spotlights how the ADAPTABLE study, which was launched in 2016 by PCORI and the Duke [...]
McClellan Stresses Need for RWE Infrastructure
Duke-Margolis' Mark McClellan tells The Pink Sheet a robust real-world evidence infrastructure is needed, and that RWE studies should be [...]
Thompson Spotlights Virtual Research
Syneos Health's David Thompson in a recent Value & Outcomes Spotlight article spotlights how drugmakers are dealing with increased emphasis [...]
Cytel Outlines Use of Bayesian Methodologies
A new white paper from Cytel outlines how its statisticians have used Bayesian methodologies in the search for effective COVID-19 [...]
Cytel Offers On-Demand Access to Webinar on Synethic, External Control Arms
A new on-demand webinar from Cytel offers insights into synthetic and external control arms in clinical trials. The webinar features [...]
Cytel Paper Offers Insight into Trial Recruitment Targets
A new white paper from Cytel offers insight into how recruitment targets are "met with sound starting assumptions and key [...]
Analysis Finds Clinical Trial Costs are Actually Modest
A new analysis published in BMJ Open suggests that clinical trial costs for new drugs are generally modest, according to [...]
Phesi President Talks Impact of Pandemic on Trials, Supports Data-Driven Approach
Phesi Founder and President Gen Li in a recent interview with Outsourcing-Pharma discussed how the COVID-19 pandemic is affecting clinical [...]
Cytel Releases New Primer, Ebook on Synthetic Control Arms
Cytel has released a new ebook outlining the use cases and benefits of synthetic control arms in clinical trial settings, [...]
Collecting Data in the Midst of a Pandemic
Evidera's Mariah Baltezegar in a recent blog post considers how to best collect data during the COVID-19 pandemic. Baltezegar writes [...]
Addressing a Prominent Health Burden Using Real World Evidence: Management of Heart Failure with Preserved Ejection Fraction
Heart Failure: Common, Debilitating and Growing Public Health Issue Heart failure (HF) is a complex, debilitating syndrome affecting an [...]
Narayanan: RWD Not a Replacement for Clinical Trials
In a recent interview with the American Journal of Managed Care (AMJC), COTA Healthcare Vice President of Life Sciences Viraj [...]
Changing the Clinical Trial Paradigm for Rare and Orphan (R&O) Diseases using Real-World Evidence
Interview with Flora Sandra Siami, MPH. Vice President of Clinical Research, Regulatory Affairs, and Quality Assurance at HealthCore-NERI. Dr. Patti [...]
Advancing Real-World Evidence with Pragmatic Clinical Trials: Interview with Dr. Joseph Singer, Chief Medical Officer of HealthCore-NERI
Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Dr. Joseph Singer, CMO of HealthCore-NERI, to discuss how pragmatic clinical [...]
WHEN 1+1=3: HOW ELECTRONIC HEALTH RECORDS AND CLAIMS CAN BE USED SYNERGISTICALLY
Sponsored blog posting by DaVita Clinical Research. 1. Combining Drug Development with Real-World Data Analytics DaVita Clinical Research® (DCR®), a [...]
Real-World Evidence Studies: Checking it Once, Checking it Twice…
By now, either through posts on this tHEORetically Speaking blog, the official blog of HealthEconomics.Com, or through your own personal [...]
Real-World Evidence: Why Patients Matter.
"Take 2 tablets and call me in the morning" We've moved, finally, beyond assuming that an off-the-cuff statement like “take [...]
Is Your RWE Study In the Weeds? Meet Some Experts Who Can Help.
This year, you can’t swing the proverbial “dead cat” without running into a meeting on Real World Evidence. This flurry [...]
Achieving Market Access in India – Are You Hitting the Mark? An Interview with Marksman Healthcare Solutions CEO Dr. Amit Dang
It’s well-accepted that the Indian pharmaceuticals market cannot be ignored. India will be one of the top 10 sales markets [...]